Top Companies in the Veterinary Infectious Disease Diagnostics

The global veterinary infectious disease diagnostics market is projected to reach USD 4.22 billion by 2030 from USD 2.87 billion in 2025, growing at a CAGR of 8.0% during the forecast period. The growth of the global veterinary infectious disease diagnostics market can be primarily attributed to several factors. These include an increasing population of companion animals, heightened concerns regarding infectious zoonotic diseases, the rising demand for animal-derived food products, and the increased demand for pet insurance. Additionally, growing expenditures on animal health, the rising number of veterinary practitioners, higher disposable incomes in developed markets, and the expanding focus on disease control and prevention measures also contribute to market growth.

However, certain challenges could impact this growth. High costs associated with veterinary diagnostic tests and rising pet care expenses may restrain market expansion to some extent. Furthermore, low awareness of animal healthcare and a shortage of veterinary practitioners in emerging economies pose significant challenges for leading companies in the market.

To know about the assumptions considered for the study download the pdf brochure

The prominent players in the veterinary infectious disease diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), Virbac (France), bioMérieux (France), Antech Diagnostics, Inc. (US), Innovative Diagnostics (France), Neogen Corporation (US), INDICAL BIOSCIENCE GmbH (Germany), Agrolabo S.p.A. (Italy), and BioNote (South Korea). These companies have adopted a range of growth strategies, both organic and inorganic. These strategies include launching new products, forming strategic partnerships, and exploring emerging markets. The goal of these initiatives is to increase market share and diversify their portfolios.

• In June 2025, bioMérieux (France) introduced VETFIRE, a ready-to-use PCR kit designed specifically for equine infectious respiratory diseases. This kit allows for the simultaneous detection of seven infectious respiratory pathogens in horses.
• In May 2023, Virbac acquired GS Partners, which has now become part of the Virbac Group. This acquisition has strengthened Virbac's position in the veterinary infectious disease diagnostics market.

IDEXX Laboratories Inc. (US) is a global medical technology company focused on products and services for companion animals, livestock, poultry, dairy, and water testing. It operates through four segments: Companion Animal Group (CAG), Water Quality Products, Livestock, Poultry and Dairy (LPD), and Others. The CAG segment includes diagnostic solutions and veterinary software, while the LPD segment offers diagnostic products for various farm animals. The company has sales offices in leading regions and markets its products in over 175 countries. In 2023, the CAG segment reported a revenue growth of 6.4%, driven by increased testing volumes and higher unit sales prices. In 2024, 5.6% of the total revenue was allocated to research and development.

Zoetis Services LLC (US) focuses on discovering, developing, and commercializing animal health products, including vaccines, medicines, diagnostics, and genetic tests for companion animals (like dogs and cats) and livestock (such as cattle and poultry). Operating in the US and internationally, it offers a range of product categories, including anti-infectives, vaccines, and diagnostics. Its immunodiagnostic products use tests like ELISA and rapid immune migration. With operations in 45 countries and products sold in over 100, the company has over 300 R&D programs and spent USD 686 million on expenses. In January 2024, it expanded its Vetscan Imagyst platform to include AI Urine Sediment analysis for diagnosing infections like UTIs.

Market Ranking:

The top five companies in the veterinary infectious disease diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), Virbac (France), and bioMérieux (France). IDEXX Laboratories stands out as a key player in the market, experiencing an increase in revenue from its reference laboratory diagnostic and consulting services, attributed to higher testing volumes and increased average unit sales prices in the US.

Zoetis is also a leading company in this market due to its extensive portfolio of diagnostic systems, including approximately 300 comprehensive product lines for companion animals and livestock.

Thermo Fisher Scientific is recognized as a major competitor in the veterinary infectious disease diagnostics space, owing to its strong brand recognition and wide range of diagnostic products and instruments.

Virbac holds a solid position in the market, bolstered by its long-standing expertise in animal health and a dedicated portfolio of rapid diagnostic solutions.

Related Reports:

Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com